Advertisement
UK markets close in 1 hour 20 minutes
  • FTSE 100

    8,132.26
    +53.40 (+0.66%)
     
  • FTSE 250

    19,823.88
    +221.90 (+1.13%)
     
  • AIM

    755.56
    +2.44 (+0.32%)
     
  • GBP/EUR

    1.1676
    +0.0020 (+0.17%)
     
  • GBP/USD

    1.2502
    -0.0009 (-0.07%)
     
  • Bitcoin GBP

    51,470.85
    +667.00 (+1.31%)
     
  • CMC Crypto 200

    1,337.69
    -58.85 (-4.21%)
     
  • S&P 500

    5,101.50
    +53.08 (+1.05%)
     
  • DOW

    38,280.85
    +195.05 (+0.51%)
     
  • CRUDE OIL

    83.95
    +0.38 (+0.45%)
     
  • GOLD FUTURES

    2,353.00
    +10.50 (+0.45%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,156.21
    +238.93 (+1.33%)
     
  • CAC 40

    8,095.48
    +78.83 (+0.98%)
     

Global Contrast Media Market to Reach US$6.4 Billion by the Year 2027

Abstract: Global Contrast Media Market to Reach US$6. 4 Billion by the Year 2027. Amid the COVID-19 crisis, the global market for Contrast Media estimated at US$4.

New York, July 22, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Contrast Media Industry" - https://www.reportlinker.com/p05798259/?utm_source=GNW
9 Billion in the year 2020, is projected to reach a revised size of US$6.4 Billion by 2027, growing at a CAGR of 3.9% over the analysis period 2020-2027.X-ray/Computed Tomography (CT), one of the segments analyzed in the report, is projected to grow at a 3.9% CAGR to reach US$2.9 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Magnetic Resonance Imaging (MRI) segment is readjusted to a revised 3.4% CAGR for the next 7-year period. This segment currently accounts for a 30.7% share of the global Contrast Media market.

The U.S. Accounts for Over 27% of Global Market Size in 2020, While China is Forecast to Grow at a 6.2% CAGR for the Period of 2020-2027

The Contrast Media market in the U.S. is estimated at US$1.3 Billion in the year 2020. The country currently accounts for a 27.04% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$1.3 Billion in the year 2027 trailing a CAGR of 6.2% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.3% and 3.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR while Rest of European market (as defined in the study) will reach US$1.3 Billion by the year 2027.

Ultrasound Segment Corners a 24% Share in 2020

In the global Ultrasound segment, USA, Canada, Japan, China and Europe will drive the 4.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$894.3 Million in the year 2020 will reach a projected size of US$1.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$845.2 Million by the year 2027, while Latin America will expand at a 4.7% CAGR through the analysis period.

Select Competitors (Total 45 Featured)

  • AMAG Pharmaceuticals, Inc.

  • Bayer AG

  • Daiichi Sankyo Co., Ltd.

  • GE Healthcare

  • Guerbet Group

  • Starpharma Holdings Limited




Read the full report: https://www.reportlinker.com/p05798259/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
Impact of Covid-19 and a Looming Global Recession
Prevalence of Chronic Diseases Among the Growing Global
Population Pushes Up the Diagnostic Burden & Demand for
Imaging
EXHIBIT 1: Rising Prevalence of Chronic Diseases Amplifies the
Volume of Imaging Procedures, Driving Opportunities for
Imaging Agents: Global Cost of Chronic Diseases (In US$
Billion) for the Years 2018 and 2030
EXHIBIT 2: The US$ 37 Billion Robustly Growing Medical Imaging
Market Provides Lucrative Opportunities for Contrast Agents
for Advanced Visualization: Global Medical Imaging Market
(In US$ Billion) for the Years 2018, 2020 and 2022
Aging Population, a Demographic Catalyst Driving Demand for
Imaging Services
Rapidly Aging Population & the Challenges Associated With
Geriatric Imaging Spurs Demand for Contrast Imaging Agents:
Global Population of 65+ Individuals (In 000s) by Region for
the Years 2015, 2020 & 2025
Rise of Nuclear Medicine, the Cornerstone for the Growth for
Radioactive Tracers
EXHIBIT 3: Improving Quality & Value of Nuclear Medicine Bodes
Well for Radioactive Contrast Agents: Global Market for
Nuclear Imaging (US$ Billion) for the Years 2018, 2020, 2022
and 2025 by Type
Short Supply of Technetium-99m Threatens to Impact Nuclear
Imaging Services
EXHIBIT 4: Plagued by the Risk of Reactor Decommissioning &
Unplanned Maintenance Shutdowns, Fragile Supply of Mo-99 Will
Remain a Cause for Concern: Global Mo-99 Production Capacity
(In Curies (Ci) Per Week) by Producer for the Years 2016
through 2022

2. FOCUS ON SELECT PLAYERS
AMAG Pharmaceuticals, Inc. (USA)
Bayer Healthcare LLC (USA)
Bracco Imaging SpA (Italy)
GE Healthcare (USA)
Genovis AB (Sweden)
Guerbet Group (France)
J.B. Chemicals & Pharmaceuticals Ltd. (India)
Jodas Expoim (India)
Lantheus Medical Imaging, Inc. (USA)
Magnus Health (India)
Medtronic Plc. (Ireland)
nanoPET Pharma GmbH (Germany)
Sanochemia Pharmazeutika AG (Austria)
Spago Nanomedical AB (Sweden)
Taejoon Pharm Co., Ltd. (South Korea)
Unijules Life Sciences Ltd. (India)

3. MARKET TRENDS & DRIVERS
Migration to Value Based Care Throws the Focus on Quality &
Value of Imaging & Its Ability to Improve Patient Care by
Providing Better Quality Images
EXHIBIT 5: With ?Value? being the new Currency in Healthcare
Markets Worldwide, Value Based Imaging Will Positively Impact
Contrast Enhanced Imaging Procedures: % of Value-Based
Reimbursement (VBR) & Fee-For-Service Structured Healthcare
Organizations for the Years 2016, 2018 and 2022
Growing Preference for Non-Ionizing Radiation-Based
Radioimaging Drives Demand for Contrast Enhanced MRI
Commercially Available MRI Contrast Agents
EXHIBIT 6: Spurred by Safety & Efficiency Benefits, Growing MRI
Procedures & Parallel Increase in MRI Machines to Benefit
Demand for MRI Contrast Agents: Global MRI Equipment Market
(In US$ Billion) for the Years 2018, 2020, 2022 and 2024
EXHIBIT 7: Equipment Density Correlates With Number of Imaging
Procedures: Magnetic Resonance Imaging (MRI) Units in Select
Countries (Per Million Population) for the Year 2019
Evolving Clinical Applications of Contrast-Enhanced Ultrasound
(CEUS) Drive Demand for Ultrasound Contrast Agents
Clinically Available Ultrasound Contrast Agents
Growing Use of CEUS in Emergency and Critical Care
Special Focus on Microbubble Contrast Agents for Ultrasound
Imaging
Clinical Applications of Microbubbles
Oscillating Microbubbles: To Revolutionize Ultrasound
EXHIBIT 8: Growing Market for Ultrasound Equipment Pushes Up
the Number of CEUS Procedures Performed: Global Market for
Ultrasound Equipment (In US Billion) for the Years 2017,
2019, 2022 and 2024
Continued Value of CT Imaging in Cardiology Despite Risk of
Radiation Exposure Drives Demand for Contrast-Enhanced CT
Contrast Agents Used in CT Imaging by Class: A Snapshot
CCTA Gaining Traction in Coronary Arteries Imaging
List of Iodine-Containing Contrast Agents for Coronary CT
Angiography
EXHIBIT 9: Growing Access to CT Imaging Bodes Well for CT
Contrast Agents: Density of CT Scanners in Select Countries:
(Per Million Population) for the Year 2019
Rise in Image Guided Surgeries Drives Demand for Contrast Agents
Emergence of Molecular-Targeted Fluorescent Tracers
Select Potential ?always-on? Targeted Tracers for Fluorescence
Image-Guided Surgery (FIGS)
The Use of Gold Nanoclusters as Contrast Agent for IGS of Head
and Neck Tumors
EXHIBIT 10: Better Surgical Outcome Drives the Number of Image
Guided Surgeries Performed Worldwide Along with Demand for
Contrast Agents: Global Market for Image Guided Surgical
Devices (In US$ Billion) for the Years 2018, 2020, and 2022
by Imaging Type
Stringent Guidelines & Implementation of Best Practices for
Safe Use of Contrast Agents to Encourage Patient Acceptance of
Contrast Enhanced Imaging
Safety Issues with Iodinated Agents, Gadolinium BCA and
Microbubbles
Symptoms of Reaction to Administration of Iodinated Contrast
Media Agents
Innovations Remain Crucial to Growth
A Review of Advancements in Contrast Media Injector Technology
Development of New Contrast Agents
Key Challenges Confront the Market
Advances in Imaging Technology Reduce Contrast Media Use
Product Recalls and Side Effects of Contrast Media Challenge
Growth
A Snapshot of Side Effects, Allergic and Adverse Reactions with
Contrast Agents

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Contrast Media by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Contrast Media by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Contrast Media by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for X-ray/Computed
Tomography (CT) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for X-ray/Computed Tomography
(CT) by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for X-ray/Computed
Tomography (CT) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 7: World Current & Future Analysis for Magnetic Resonance
Imaging (MRI) by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Magnetic Resonance Imaging
(MRI) by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Magnetic Resonance
Imaging (MRI) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 10: World Current & Future Analysis for Ultrasound by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Ultrasound by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Ultrasound by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Barium-based
Contrast Media by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Barium-based Contrast Media
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Barium-based Contrast
Media by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 16: World Current & Future Analysis for Iodinated
Contrast Media by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Iodinated Contrast Media by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Iodinated Contrast
Media by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 19: World Current & Future Analysis for Gadolinium-based
Contrast Media by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Gadolinium-based Contrast
Media by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Gadolinium-based
Contrast Media by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 22: World Current & Future Analysis for Microbubble
Contrast Media by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Microbubble Contrast Media
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Microbubble Contrast
Media by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 25: World Current & Future Analysis for Radiology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Radiology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 27: World 15-Year Perspective for Radiology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Interventional
Radiology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Interventional Radiology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Interventional
Radiology by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 31: World Current & Future Analysis for Interventional
Cardiology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 32: World Historic Review for Interventional Cardiology
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 33: World 15-Year Perspective for Interventional
Cardiology by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

III. MARKET ANALYSIS

UNITED STATES
Table 34: USA Current & Future Analysis for Contrast Media by
Imaging Modality - X-ray/Computed Tomography (CT), Magnetic
Resonance Imaging (MRI) and Ultrasound - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 35: USA Historic Review for Contrast Media by Imaging
Modality - X-ray/Computed Tomography (CT), Magnetic Resonance
Imaging (MRI) and Ultrasound Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 36: USA 15-Year Perspective for Contrast Media by Imaging
Modality - Percentage Breakdown of Value Sales for
X-ray/Computed Tomography (CT), Magnetic Resonance Imaging
(MRI) and Ultrasound for the Years 2012, 2020 & 2027

Table 37: USA Current & Future Analysis for Contrast Media by
Type of Media - Barium-based Contrast Media, Iodinated Contrast
Media, Gadolinium-based Contrast Media and Microbubble Contrast
Media - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 38: USA Historic Review for Contrast Media by Type of
Media - Barium-based Contrast Media, Iodinated Contrast Media,
Gadolinium-based Contrast Media and Microbubble Contrast Media
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 39: USA 15-Year Perspective for Contrast Media by Type of
Media - Percentage Breakdown of Value Sales for Barium-based
Contrast Media, Iodinated Contrast Media, Gadolinium-based
Contrast Media and Microbubble Contrast Media for the Years
2012, 2020 & 2027

Table 40: USA Current & Future Analysis for Contrast Media by
Application - Radiology, Interventional Radiology and
Interventional Cardiology - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 41: USA Historic Review for Contrast Media by Application -
Radiology, Interventional Radiology and Interventional
Cardiology Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 42: USA 15-Year Perspective for Contrast Media by
Application - Percentage Breakdown of Value Sales for
Radiology, Interventional Radiology and Interventional
Cardiology for the Years 2012, 2020 & 2027

CANADA
Table 43: Canada Current & Future Analysis for Contrast Media
by Imaging Modality - X-ray/Computed Tomography (CT), Magnetic
Resonance Imaging (MRI) and Ultrasound - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 44: Canada Historic Review for Contrast Media by Imaging
Modality - X-ray/Computed Tomography (CT), Magnetic Resonance
Imaging (MRI) and Ultrasound Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 45: Canada 15-Year Perspective for Contrast Media by
Imaging Modality - Percentage Breakdown of Value Sales for
X-ray/Computed Tomography (CT), Magnetic Resonance Imaging
(MRI) and Ultrasound for the Years 2012, 2020 & 2027

Table 46: Canada Current & Future Analysis for Contrast Media
by Type of Media - Barium-based Contrast Media, Iodinated
Contrast Media, Gadolinium-based Contrast Media and Microbubble
Contrast Media - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 47: Canada Historic Review for Contrast Media by Type of
Media - Barium-based Contrast Media, Iodinated Contrast Media,
Gadolinium-based Contrast Media and Microbubble Contrast Media
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for Contrast Media by Type
of Media - Percentage Breakdown of Value Sales for Barium-based
Contrast Media, Iodinated Contrast Media, Gadolinium-based
Contrast Media and Microbubble Contrast Media for the Years
2012, 2020 & 2027

Table 49: Canada Current & Future Analysis for Contrast Media
by Application - Radiology, Interventional Radiology and
Interventional Cardiology - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 50: Canada Historic Review for Contrast Media by
Application - Radiology, Interventional Radiology and
Interventional Cardiology Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 51: Canada 15-Year Perspective for Contrast Media by
Application - Percentage Breakdown of Value Sales for
Radiology, Interventional Radiology and Interventional
Cardiology for the Years 2012, 2020 & 2027

JAPAN
Table 52: Japan Current & Future Analysis for Contrast Media by
Imaging Modality - X-ray/Computed Tomography (CT), Magnetic
Resonance Imaging (MRI) and Ultrasound - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 53: Japan Historic Review for Contrast Media by Imaging
Modality - X-ray/Computed Tomography (CT), Magnetic Resonance
Imaging (MRI) and Ultrasound Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 54: Japan 15-Year Perspective for Contrast Media by
Imaging Modality - Percentage Breakdown of Value Sales for
X-ray/Computed Tomography (CT), Magnetic Resonance Imaging
(MRI) and Ultrasound for the Years 2012, 2020 & 2027

Table 55: Japan Current & Future Analysis for Contrast Media by
Type of Media - Barium-based Contrast Media, Iodinated Contrast
Media, Gadolinium-based Contrast Media and Microbubble Contrast
Media - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 56: Japan Historic Review for Contrast Media by Type of
Media - Barium-based Contrast Media, Iodinated Contrast Media,
Gadolinium-based Contrast Media and Microbubble Contrast Media
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 57: Japan 15-Year Perspective for Contrast Media by Type
of Media - Percentage Breakdown of Value Sales for Barium-based
Contrast Media, Iodinated Contrast Media, Gadolinium-based
Contrast Media and Microbubble Contrast Media for the Years
2012, 2020 & 2027

Table 58: Japan Current & Future Analysis for Contrast Media by
Application - Radiology, Interventional Radiology and
Interventional Cardiology - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 59: Japan Historic Review for Contrast Media by
Application - Radiology, Interventional Radiology and
Interventional Cardiology Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 60: Japan 15-Year Perspective for Contrast Media by
Application - Percentage Breakdown of Value Sales for
Radiology, Interventional Radiology and Interventional
Cardiology for the Years 2012, 2020 & 2027

CHINA
Table 61: China Current & Future Analysis for Contrast Media by
Imaging Modality - X-ray/Computed Tomography (CT), Magnetic
Resonance Imaging (MRI) and Ultrasound - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 62: China Historic Review for Contrast Media by Imaging
Modality - X-ray/Computed Tomography (CT), Magnetic Resonance
Imaging (MRI) and Ultrasound Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 63: China 15-Year Perspective for Contrast Media by
Imaging Modality - Percentage Breakdown of Value Sales for
X-ray/Computed Tomography (CT), Magnetic Resonance Imaging
(MRI) and Ultrasound for the Years 2012, 2020 & 2027

Table 64: China Current & Future Analysis for Contrast Media by
Type of Media - Barium-based Contrast Media, Iodinated Contrast
Media, Gadolinium-based Contrast Media and Microbubble Contrast
Media - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 65: China Historic Review for Contrast Media by Type of
Media - Barium-based Contrast Media, Iodinated Contrast Media,
Gadolinium-based Contrast Media and Microbubble Contrast Media
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 66: China 15-Year Perspective for Contrast Media by Type
of Media - Percentage Breakdown of Value Sales for Barium-based
Contrast Media, Iodinated Contrast Media, Gadolinium-based
Contrast Media and Microbubble Contrast Media for the Years
2012, 2020 & 2027

Table 67: China Current & Future Analysis for Contrast Media by
Application - Radiology, Interventional Radiology and
Interventional Cardiology - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 68: China Historic Review for Contrast Media by
Application - Radiology, Interventional Radiology and
Interventional Cardiology Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 69: China 15-Year Perspective for Contrast Media by
Application - Percentage Breakdown of Value Sales for
Radiology, Interventional Radiology and Interventional
Cardiology for the Years 2012, 2020 & 2027

EUROPE
Table 70: Europe Current & Future Analysis for Contrast Media
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027 and %
CAGR

Table 71: Europe Historic Review for Contrast Media by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Contrast Media by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Contrast Media
by Imaging Modality - X-ray/Computed Tomography (CT), Magnetic
Resonance Imaging (MRI) and Ultrasound - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 74: Europe Historic Review for Contrast Media by Imaging
Modality - X-ray/Computed Tomography (CT), Magnetic Resonance
Imaging (MRI) and Ultrasound Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 75: Europe 15-Year Perspective for Contrast Media by
Imaging Modality - Percentage Breakdown of Value Sales for
X-ray/Computed Tomography (CT), Magnetic Resonance Imaging
(MRI) and Ultrasound for the Years 2012, 2020 & 2027

Table 76: Europe Current & Future Analysis for Contrast Media
by Type of Media - Barium-based Contrast Media, Iodinated
Contrast Media, Gadolinium-based Contrast Media and Microbubble
Contrast Media - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 77: Europe Historic Review for Contrast Media by Type of
Media - Barium-based Contrast Media, Iodinated Contrast Media,
Gadolinium-based Contrast Media and Microbubble Contrast Media
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 78: Europe 15-Year Perspective for Contrast Media by Type
of Media - Percentage Breakdown of Value Sales for Barium-based
Contrast Media, Iodinated Contrast Media, Gadolinium-based
Contrast Media and Microbubble Contrast Media for the Years
2012, 2020 & 2027

Table 79: Europe Current & Future Analysis for Contrast Media
by Application - Radiology, Interventional Radiology and
Interventional Cardiology - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 80: Europe Historic Review for Contrast Media by
Application - Radiology, Interventional Radiology and
Interventional Cardiology Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 81: Europe 15-Year Perspective for Contrast Media by
Application - Percentage Breakdown of Value Sales for
Radiology, Interventional Radiology and Interventional
Cardiology for the Years 2012, 2020 & 2027

FRANCE
Table 82: France Current & Future Analysis for Contrast Media
by Imaging Modality - X-ray/Computed Tomography (CT), Magnetic
Resonance Imaging (MRI) and Ultrasound - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 83: France Historic Review for Contrast Media by Imaging
Modality - X-ray/Computed Tomography (CT), Magnetic Resonance
Imaging (MRI) and Ultrasound Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 84: France 15-Year Perspective for Contrast Media by
Imaging Modality - Percentage Breakdown of Value Sales for
X-ray/Computed Tomography (CT), Magnetic Resonance Imaging
(MRI) and Ultrasound for the Years 2012, 2020 & 2027

Table 85: France Current & Future Analysis for Contrast Media
by Type of Media - Barium-based Contrast Media, Iodinated
Contrast Media, Gadolinium-based Contrast Media and Microbubble
Contrast Media - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 86: France Historic Review for Contrast Media by Type of
Media - Barium-based Contrast Media, Iodinated Contrast Media,
Gadolinium-based Contrast Media and Microbubble Contrast Media
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 87: France 15-Year Perspective for Contrast Media by Type
of Media - Percentage Breakdown of Value Sales for Barium-based
Contrast Media, Iodinated Contrast Media, Gadolinium-based
Contrast Media and Microbubble Contrast Media for the Years
2012, 2020 & 2027

Table 88: France Current & Future Analysis for Contrast Media
by Application - Radiology, Interventional Radiology and
Interventional Cardiology - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 89: France Historic Review for Contrast Media by
Application - Radiology, Interventional Radiology and
Interventional Cardiology Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 90: France 15-Year Perspective for Contrast Media by
Application - Percentage Breakdown of Value Sales for
Radiology, Interventional Radiology and Interventional
Cardiology for the Years 2012, 2020 & 2027

GERMANY
Table 91: Germany Current & Future Analysis for Contrast Media
by Imaging Modality - X-ray/Computed Tomography (CT), Magnetic
Resonance Imaging (MRI) and Ultrasound - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 92: Germany Historic Review for Contrast Media by Imaging
Modality - X-ray/Computed Tomography (CT), Magnetic Resonance
Imaging (MRI) and Ultrasound Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 93: Germany 15-Year Perspective for Contrast Media by
Imaging Modality - Percentage Breakdown of Value Sales for
X-ray/Computed Tomography (CT), Magnetic Resonance Imaging
(MRI) and Ultrasound for the Years 2012, 2020 & 2027

Table 94: Germany Current & Future Analysis for Contrast Media
by Type of Media - Barium-based Contrast Media, Iodinated
Contrast Media, Gadolinium-based Contrast Media and Microbubble
Contrast Media - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 95: Germany Historic Review for Contrast Media by Type of
Media - Barium-based Contrast Media, Iodinated Contrast Media,
Gadolinium-based Contrast Media and Microbubble Contrast Media
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 96: Germany 15-Year Perspective for Contrast Media by
Type of Media - Percentage Breakdown of Value Sales for
Barium-based Contrast Media, Iodinated Contrast Media,
Gadolinium-based Contrast Media and Microbubble Contrast Media
for the Years 2012, 2020 & 2027

Table 97: Germany Current & Future Analysis for Contrast Media
by Application - Radiology, Interventional Radiology and
Interventional Cardiology - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 98: Germany Historic Review for Contrast Media by
Application - Radiology, Interventional Radiology and
Interventional Cardiology Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 99: Germany 15-Year Perspective for Contrast Media by
Application - Percentage Breakdown of Value Sales for
Radiology, Interventional Radiology and Interventional
Cardiology for the Years 2012, 2020 & 2027

ITALY
Table 100: Italy Current & Future Analysis for Contrast Media
by Imaging Modality - X-ray/Computed Tomography (CT), Magnetic
Resonance Imaging (MRI) and Ultrasound - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 101: Italy Historic Review for Contrast Media by Imaging
Modality - X-ray/Computed Tomography (CT), Magnetic Resonance
Imaging (MRI) and Ultrasound Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 102: Italy 15-Year Perspective for Contrast Media by

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05798259/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001